Regedent hosts symposium at EuroPerio11

VIENNA, Austria: Regedent is marking a big milestone at EuroPerio11 with a symposium highlighting ten years of medical enjoy with hyaDENT BG, a cross-linked hyaluronic acid (xHyA) that has performed an important position in advancing periodontal and peri-implant treatment.

Over the last decade, the mixing of hyaDENT BG with PERISOLV, a sodium hypochlorite and amino acid-based gel for subgingival decontamination, has resulted in the improvement of CLEAN&SEAL, a clinically validated protocol supporting regeneration in each surgical and non-surgical contexts.

“Medical research showed the effectiveness of non-surgical treatment with cross-linked hyaluronic acid,” mentioned Prof. Anton Sculean, who’s chairing the consultation. “In response to these kind of knowledge, the CLEAN&SEAL thought used to be presented into periodontal treatment. This represented a paradigm shift—predictable regeneration with out surgical operation.”

These days’s symposium items the newest medical and preclinical findings at the position of xHyA in periodontal and peri-implant care. Attendees achieve sensible steerage on incorporating CLEAN&SEAL into on a regular basis observe, particularly in difficult circumstances involving peri-implant mucositis and peri-implantitis.

“This tournament marks a second of mirrored image,” mentioned Lucia Calvi, CEO of Regedent. “Ten years of medical enjoy with hyaDENT BG have constructed a robust basis for contemporary regenerative protocols. We’re excited to percentage this adventure with the dental group.”

All individuals obtain a complimentary 128-page medical manual providing detailed case research and hands-on steerage for making use of the CLEAN&SEAL thought.

Regedent develops, manufactures and markets regenerative answers for oral surgical operation, guided bone regeneration and periodontology with a focal point on retaining enamel and implants. The corporate is understood for its evidence-based cross-linked hyaluronic acid gels, biofilm-removing gels, resorbable membranes and porcine bone substitutes. The CLEAN&SEAL treatment displays Regedent’s longstanding dedication to clinical collaboration and innovation. Regedent operates globally with places of work in Switzerland, Germany and Italy.

The symposium, titled “Ten years of hyaDENT BG in periodontitis and peri-implantitis” takes position lately from 12:30 to fourteen:00 within the Stolz 1 confenrence room at EuroPerio11. Extra details about the corporate will also be discovered at regedent.com.